(OPCH) Option Care Health - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US68404L2016
OPCH: Infusion, Therapy, Nutrition, Nursing, Management
Option Care Health, Inc. (NASDAQ:OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in delivering complex infusion therapies to patients with acute and chronic conditions. Its comprehensive service portfolio includes anti-infective therapy, heart failure treatment, parenteral and enteral nutrition support for conditions like stroke, cancer, and gastrointestinal diseases, immunoglobulin infusion therapies for immune deficiencies, and treatments for chronic inflammatory disorders such as Crohns disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Additionally, the company offers therapies for neurological disorders, including multiple sclerosis, Alzheimers disease, and Duchenne muscular dystrophy, as well as infusion therapies for bleeding disorders like hemophilia and von Willebrand disease. It also provides treatments for high-risk pregnancies and other conditions requiring pain management, chemotherapy, and respiratory medications, complemented by nursing services. The companys services are marketed through patient referrals from physicians, hospital discharge planners, health maintenance organizations, and preferred provider organizations. Headquartered in Bannockburn, Illinois, Option Care Health operates as a key player in the home infusion therapy market, offering cost-effective, patient-centric care in non-traditional settings. Web URL: https://www.optioncarehealth.com
Based on the provided data, here is the 3-month forecast:
Over the next three months, OPCH is expected to trade within a narrow range, with potential resistance at $34.50 and support at $31.50. The stock is likely to remain range-bound due to its proximity to the 20-day and 50-day moving averages. The ATR of 1.03 suggests moderate volatility, with potential price swings of $0.50-$1.00 per session. Fundamental analysis indicates strong revenue growth potential, supported by a P/S ratio of 1.06 and an ROE of 15.08, which may drive upward momentum. However, the current P/E of 26.16 and forward P/E of 21.83 suggest investors are pricing in future growth. The stock may experience sideways consolidation before breaking out above the 50-day SMA of $33.29.
Additional Sources for OPCH Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
OPCH Stock Overview
| Market Cap in USD | 5,395m |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| GiC Sub-Industry | Health Care Services |
| IPO / Inception | 1996-08-15 |
OPCH Stock Ratings
| Growth Rating | 70.8 |
| Fundamental | 58.7 |
| Dividend Rating | 0.0 |
| Rel. Strength | 14.3 |
| Analysts | 4.5/5 |
| Fair Price Momentum | 35.26 USD |
| Fair Price DCF | 45.31 USD |
OPCH Dividends
No Dividends PaidOPCH Growth Ratios
| Growth Correlation 3m | 10.1% |
| Growth Correlation 12m | 40.8% |
| Growth Correlation 5y | 73.4% |
| CAGR 5y | 22.32% |
| CAGR/Max DD 5y | 0.57 |
| Sharpe Ratio 12m | 0.71 |
| Alpha | 4.65 |
| Beta | 0.253 |
| Volatility | 47.38% |
| Current Volume | 2035.6k |
| Average Volume 20d | 2167.7k |
As of May 09, 2025, the stock is trading at USD 33.44 with a total of 2,035,609 shares traded.
Over the past week, the price has changed by +3.50%, over one month by +1.73%, over three months by +7.94% and over the past year by +10.29%.
Partly, yes. Based on ValueRay Fundamental Analyses, Option Care Health (NASDAQ:OPCH) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 58.73 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of OPCH as of May 2025 is 35.26. This means that OPCH is currently overvalued and has a potential downside of 5.44%.
Option Care Health has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy OPCH.
- Strong Buy: 6
- Buy: 3
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, OPCH Option Care Health will be worth about 38.1 in May 2026. The stock is currently trading at 33.44. This means that the stock has a potential upside of +13.91%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 38.6 | 15.3% |
| Analysts Target Price | 38.6 | 15.3% |
| ValueRay Target Price | 38.1 | 13.9% |